Home › Breast Cancer › Nebraska › Lincoln
Breast Cancer clinical trials in Lincoln, NE
4 studies for Breast Cancer are looking for participants at sites in and around Lincoln (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecruitingPhase 3
- Cancer Partners of Nebraska ( Site 0068), Lincoln
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecruitingPhase 3
- NHO Revive Research Institute LLC, Lincoln
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
RecruitingPhase 2
- Cancer Partners of Nebraska, Lincoln
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecruitingPhase 3
- Cancer Partners of Nebraska, Lincoln
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA110 studies
- Nashville, TN79 studies
- Los Angeles, CA71 studies
- Edison, NJ69 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX54 studies
Other studies in Lincoln
- Non-Small Cell Lung Cancer16 studies
- Heart Failure8 studies
- Lung Cancer7 studies
- Coronary Artery Disease5 studies
- Colorectal Cancer4 studies
- Obesity4 studies
- Schizophrenia4 studies
- Melanoma3 studies
- Multiple Myeloma3 studies
- Amyotrophic Lateral Sclerosis3 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.